Background Organ-specific complications (OSC) remain serious potential sequela of gastrointestinal surgery. Hypophosphatemia correlates with poor outcomes and may be a harbinger of OSC after gastrointestinal surgery. Our goal was to describe and evaluate the relationship between postoperative phosphate levels and OSC. Methods Consecutive patients who underwent pancreatic, colorectal, or gastric resections were analyzed. OSC were defined as those resulting from the failure of at least one anastomosis performed during the primary resection, manifesting as an anastomotic leak, fistula, and/or intra-abdominal abscess. Postoperative serum phosphate levels and other recognized OSC risk factors were compared among patients who did and did not develop OSC. Results A total of 8034 patients who underwent pancreatic (n = 397), colorectal (n = 5808), or gastric (n = 1829) resections were included in the study. In each resection group, the majority of patients experienced hypophosphatemia postresection with the nadir on postoperative day (POD) 2, and the subgroups that developed OSC exhibited lower phosphate levels on POD3-7. On multivariate analysis, lower phosphate level on POD3 remained significantly associated with OSC following pancreatic resection [median (interquartile range) Conclusion This study identified a consistent trajectory of serum phosphate levels following 3 different gastrointestinal operations and association between early postoperative phosphate levels and OSC. Persistent lower phosphate levels should raise the level of concern for evolving postoperative leak and may lead to earlier radiographic evaluation and treatment.
Introduction
Hypophosphatemia is common in hospitalized patients, ranging from 0.2 to 3% in all inpatients [1, 2] , 30% in intensive care unit patients [3, 4] , 40% in severe burn patients [5] , 75% in severe trauma patients [6] , and to 60-85% in patients with infection and sepsis [7] . Additionally, hypophosphatemia has been reported after many surgical procedures, including hepatic resection [8, 9] , thoracic surgery [10] , cardiac and aortic surgery [11, 12] . As the majority of these studies did not adjust for confounding variables, the cause for hypophosphatemia is unclear. However, a consistent association remains between hypophosphatemia and poor clinical outcomes in various populations of hospitalized patients [3, 4, [13] [14] [15] .
Complications related to postoperative fistula, leak, and abscess are serious sequelae of gastrointestinal resections. Following pancreatic resection, the reported rates of these complications range between 10 and 30% [16, 17] . Pancreatic fistula is typically associated with significant perioperative morbidity, notably hemorrhage, sepsis, longer length of hospital stay, increased cost, and higher risk of perioperative mortality [16] [17] [18] [19] . However, current risk assessment for leak-related complications is inadequate and infrequently affects management algorithms (i.e., drain placement and removal, prophylactic somatostatin analogues, prophylactic jejunostomy feeding tubes, early discharge, and discharge disposition). In a similar way, anastomotic leak is one of the most concerning complications in patients undergoing gastric [20] and colorectal resection [21] . Thus, there is a need to find markers of postoperative organ-specific complications (OSC) to facilitate early diagnosis and intervention in order to mitigate more serious sequelae.
The incidence and clinical correlates of hypophosphatemia after pancreatic, gastric, or colorectal resections have not been reported. We hypothesized that patients with OSC after gastrointestinal surgery will have significantly lower phosphate level as compared to patients without OSC.
Materials and methods

Study patients
With the approval of Memorial Sloan Kettering Cancer Center (MSKCC) institutional review board, query of prospectively maintained, service-specific databases was performed. This search identified consecutive patients who underwent pancreatic (1/2011-12/2012), gastric (1/2002-9/ 2015) , or colorectal resection (1/2005-7/2015) for any diagnosis. Different time periods were included because of differences in the individual databases utilized. Only patients that underwent initial resections were included; patients underwent reoperations were excluded.
Patient demographic information and clinicopathological characteristics were obtained. Operative morbidity was recorded and graded in the MSKCC surgical events database [17, [22] [23] [24] [25] [26] . This database uses a severity scale similar to others previously published and is consistent with the ''Common Terminology Criteria for Adverse Events Version 4.0,'' endorsed by the National Institutes of Health and the National Cancer Institute (Supplementary Tables 1  and 2 ) [25, 26] . Postoperative leak-related complications (LRC) included pancreatic anastomotic leak, pancreatic fistula, or intra-abdominal abscess, as coded in MSKCC's Secondary Surgical Events program (Supplementary  Table 1 ) [17, 25, 26] . Only clinically significant (Cgrade 2) LRC were recorded [17] . Postoperative intra-abdominal infections (IAI) after colorectal surgery included intestinal or rectal leak, intestinal or rectal fistula, or intra-abdominal infection (Supplementary Table 2 ), whereas postoperative IAI after gastric resection included esophageal or intestinal leak, esophageal or intestinal fistula, or intra-abdominal infection (Supplementary Table 2 ) [20, 25, 26] . OSC were defined as either LRC or IAI, and all complications were recorded within 90 days after operation.
Serum phosphate levels were collected from the preoperative clinic visit (within 2 weeks of operation) and then daily starting on the day of surgery and continuing through the date of discharge. Hypophosphatemia was defined as serum levels less than 2.4 mg/dL (\0.77 mmol/ L) as per MSKCC Department of Laboratory Medicine calibration and in consistent with prior studies [13, 27] . Phosphate serum levels are controlled mainly by the kidney and therefore we used the chronic kidney disease epidemiology collaboration (CKD-EPI) formula to evaluate the kidney function by obtaining preoperative serum creatinine measurements and estimating the glomerular filtration rate (GFR) [28] . Patients with preoperative GFR \ 60 mL/min/1.73 m 2 or age \ 18 years were excluded from the study (n = 2362). Postoperative phosphate repletions over the first three postoperative days were also documented. In addition, serum white blood cell counts (WBC) on postoperative day 3 were obtained to control for an established marker of acute-phase response.
Statistical analysis
Categorical variables were presented using frequency and percentage and compared using Chi-square test. Continuous variables were presented using the median with the first and third interquartile quartiles (IQR) for phosphate levels and the entire range for all other variables and compared using Mann-Whitney test. A p value \ 0.05 was considered significant. All variables with a p value \ 0.05 on univariate analysis were entered into a multivariate logistic regression with backward Wald method with criteria for removal of p value C 0.05. Separate multivariate models were created from phosphate level of each postoperative day with other OSC risk factors identified from univariate analysis for each of the three resected cohorts. Descriptive and comparative statistics were performed using SPSS version 22 (IBM Corp., Armonk, NY) and SAS 9.4 (SAS Institute, Cary, NC). Figures are plotted using GraphPad Prism (GraphPad Software, CA).
Results
Patient characteristics
During the study period, the pancreatic resection group included 397 patients, of whom 268 (68%) underwent Whipple, and 77 (19%) developed LRC C grade 2 within 90 days postoperatively (Table 1 and Supplementary  Table 1 ). The colorectal resection group included 5808 patients, of whom 2456 (42%) underwent rectal resection, and 345 (6%) developed IAI ( Table 2 and Supplementary  Table 2 ). The gastric resection group included 1829 patients, of whom 864 (45%) underwent esophagogastric resection, and 183 (10%) patients developed IAI (Table 3  and Supplementary Table 2 ). In this consecutive series of resected patients in each group, the majority of the operations were for cancer. The median lengths of stays were 7 (IQR 6-9), 7 (IQR 5-9), and 9 (IQR 7-12) days for pancreatic, colorectal, and gastric resections, respectively.
Phosphate levels
Perioperative serum phosphate alterations for patients in each resection group (pancreatic, colorectal, and gastric) are depicted (Fig. 1a-c, respectively) . In all three groups, phosphate levels declined steadily postoperatively and noted the most significant hypophosphatemia as it reached nadir on POD2. The serum phosphorus levels on preoperative day, POD0, POD1, and POD2, were not statistically different between the patients who developed OSC and those who did not. However, the serum phosphate trajectories began to separate after POD2, with the patients who developed OSC showing a slower recovery of hypophosphatemia from POD3 through POD7.
Organ-specific complications
Since patients who developed OSC had significantly lower phosphate levels on POD3-POD7 compared to those without OSC in univariate analysis, we further evaluated this relationship in the multivariate analysis with other pertinent OSC risk factors. In the pancreatic resection group, body mass index (BMI) C 30 kg/m 2 , soft pancreatic gland, abnormal WBC levels on POD3, and lower phosphate levels on POD3 were independently associated with LRC (Table 1) . Lower phosphate levels on POD5 were also independently associated with LRC in a separate multivariate analysis (Supplementary Table 3 ). In the colorectal resection group, combined liver surgery, operative blood loss, abnormal WBC levels on POD3, and lower phosphate levels on POD3 remained significantly associated with IAI (Table 2 ). Lower phosphate levels on POD4 and 5 were also independently associated with LRC in separate multivariate analyses (Supplementary Table 4) . Following gastric resection, only BMI C 30 kg/m 2 and lower phosphate levels on POD4 were independently associated with IAI (Table 3) . Lower phosphate levels on POD5 were also independently associated with IAI in a separate multivariate analysis (Supplementary Table 5 ).
Phosphate supplementation
Although phosphate supplementation was not standardized, phosphate supplementation on POD0-3 was not associated with a significantly higher rate of OSC compared to no supplementation (Tables 1, 2, 3 ). In addition, in patients with available data on daily phosphate supplementation (pancreatectomy group), those who received supplementation had a significant increase in phosphate level on the following day, and these levels were comparable to those given no supplementation. Despite receiving phosphate supplementation on POD2 following partial pancreatectomy, these patients continued Table 3 POD2 BMI body mass index, PDAC pancreatic ductal adenocarcinoma, IPMN intraductal papillary mucinous neoplasm, PNET pancreatic neuroendocrine tumor, WBC white blood cell count, NA not analyzed 
Discussion
This study identified a consistent pattern of hypophosphatemia in a large number of patients following three different gastrointestinal operations. In addition, lower phosphate levels were associated with increased risk of OSC, independent of other established risk factors. The results suggest that early postoperative hypophosphatemia may foreshadow and allow for the early identification of patients at risk of OSC. Hypophosphatemia is a common manifestation in patients who develop infection, burn and trauma, as well as after various surgical procedures [1-8, 10-12, 29-32] . In a consistent manner, the presence of hypophosphatemia was correlated with the poor outcomes, including respiratory failure, arrhythmia, heart failure, longer length of hospital stay, and increased postoperative complications [3, 4, [13] [14] [15] . The pathophysiologic mechanism by which hypophosphatemia is associated with or predicts an adverse outcome is unclear, as phosphate metabolism is multifactorial, and phosphate levels in surgical patients may be influenced by urinary loss during volume expansion, phosphate redistribution to the intracellular compartment during respiratory alkalosis or insulin/glucose infusion, and high levels of catecholamines [33] . Depending on the type of gastrointestinal surgery, patients in this study may not have any PO intake during early postoperative days. Majority of patients received normal saline or lactated ringer as resuscitative fluid for the first 24 h, and then they were switched to dextrose 5% in 1/2 normal saline ? 20 mEq/L potassium chloride as maintenance fluid on POD1 onward if they remained off diet. Although dextrose may cause transcellular shift of phosphate, this shift would be transient. In a prospective cohort study, the authors found postoperative hypophosphatemia was related to hyperphosphaturia, as likely mediated by nicotinamide phosphoribosyltransferase (NAMPT), which acted as a phosphaturic factor as well as a metabolic enzyme that synthesizes nicotinamide adenine dinucleotides [34, 35] . The role of NAMPT on OSC was not studied and it warrants additional investigation. Furthermore, whether hypophosphatemia is the symptom or cause of complication is also unclear. It may be possible that those with prolonged inflammation or infection from OSC lead to continued urinary wasting of phosphate and thus it causes both hypophosphatemia-related symptom and complications.
Several studies have evaluated hypophosphatemia in acute inflammatory or infectious state. Barak et al. [7] studied patients with infection and sepsis and showed that early hypophosphatemia was associated with the severity of infection and with higher levels of inflammatory cytokines. Moreover, injection of IL-6, TNFa and IL-1b in mice markedly decreased the serum phosphate levels. These findings were reinforced by Giovanni et al. [13] who evaluated patients after hepatic resection and demonstrated an inverse correlation between hypophosphatemia and the APACHE II score. In addition, patients with severe hypophosphatemia were associated with an almost fourfold risk of developing complications. The authors suggested that hypophosphatemia may predict complications by reflecting an early acute-phase response. It is noteworthy that recent studies have also described similar correlation between other inflammatory markers (e.g., C-reactive protein and procalcitonin) and OSC after pancreatic [36] , colorectal [21, 37] , and gastric surgery [38] .
Hypophosphatemia observed following gastrointestinal operations during the first 7 postoperative days is in line with previous reports of hypophosphatemia following hepatectomy [13, 39, 40] . The earliest difference in hypophosphatemia between the subgroups that did and did not develop OSC was noted on POD3. The importance of these time points was reported by Giaccaglia et al. [21, 41] and Meisner et al. [42] . On POD1 and 2 after intestinal surgery, they found no difference in inflammatory markers levels between the group who developed OSC and the BMI body mass index, CA cancer; WBC white blood cell count, NA not analyzed group who did not developed OSC. However, on POD3, a significant difference was observed between the groups. They proposed that a physiological increase in the inflammatory markers takes place between POD1 and 2 after intestinal surgery, which may be explained in part by a transient bacterial translocation during the operation or by preparation of the intestinal anastomosis.
The main limitation of this study relates to its retrospective, nonrandomized design in which selection factors cannot be excluded. For example, daily serum phosphate measurements from the day of resection until discharge were not complete for all patients, as shown in Tables 1, 2,  3 . In an attempt to evaluate the significance of these missing phosphate data on some patients, we have also performed analysis excluding patients who had missing phosphate levels on both POD3 and POD4 (data not shown). In that univariate analysis, those with leak were associated with significantly lower level of phosphate on POD3-7 in all 3 groups except POD6 in the colorectal group. In the multivariate analysis in the same subset of patients, lower phosphate levels were significantly associated with OSC for POD3 and 5 in the pancreatic group, POD3-5 in colorectal group, but only POD5 in gastric group. A large, prospective study mandating evaluation of daily postoperative phosphate level would be needed to minimize these selection biases. Another limitation of the study is that phosphate repletion was not standardized, although patients who received phosphate supplementation did not result in a higher rate of OSC. In addition, although patients who received phosphate supplementation had increased phosphate level on the subsequent day, they continued to have lower phosphate levels and the level was similar to those who did not require supplementation. This implies that continued metabolic and inflammatory insult from OSC might lead to persistent lower phosphate levels despite supplementation. The strength of this study is the validation of the findings provided by the consistent pattern that was observed in three different organs (i.e., pancreas, stomach, and large bowel). In the current healthcare climate, where physicians face rising challenge of delivering high-quality care against the competing front of rising healthcare cost, this work has important potential implication, as it may facilitate implementation of enhanced recovery after surgery (ERAS) [43] [44] [45] . The ERAS program may employ early postoperative hypophosphatemia to facilitate management decisions in patients who are potential candidates for early discharge. For example, patients without significant or sustained postoperative hypophosphatemia may be more reassured for earlier discharge. However, in patients with a persistent postoperative hypophosphatemia, they may not be the best candidates for early discharge. In these patients with hypophosphatemia along with other OSC risk factors, surgeons may develop a lower threshold for radiographic evaluation and drainage or may delay in removal of operative drain in order to monitor the output more closely. However, the impact of this study on ERAS patient is unclear. Since the median lengths of stay in this predominate cancer resection study were longer than one would expect from recent ERAS data, additional studies using ERAS patients is warranted although we may not be able to obtain postoperative phosphate data on some patients if they get discharged prior to POD7.
In summary, we identified a consistent trajectory of serum phosphate levels following 3 different gastrointestinal operations and an association between early postoperative lower phosphate levels and OSC. These findings may have clinical implications relevant to patients' monitoring, therapeutic interventions, and may help identify those who should not be targeted for early discharge. Future studies are warranted to determine the predictive performance of phosphate levels for OSC and in conjunction with other clinical variables.
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